Illumina's partners say they believe the company will continue to improve the speed and continue to lower the price.

San Diego-based Illumina, Inc., has launched a "production scale” sequencer that it claims can process human genomes in half a day for $200....

Centene allegedly used its subsidiary PBM to overcharge the Bay State's Medicaid program.

"When compared with non–safety net hospitals, safety-net hospitals were confronted with more concentrated financial losses," report says.

The soon-to-be shuttered hospitals in southeastern Pennsylvania, owned by Prospect Medical Holdings, Inc., will reopen as outpatient and behavioral health venues by the end of 2022.